Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-016931

EVP and Chief Legal Officer sold 5,140 shares at $62.95 ($323,563)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and Chief Legal Officer 2022-03-07 Sale −5,140 $62.95 $323,563 34,438 D: show line 1 in the form
Open-market sales · 5,140 sh · avg $62.95 · $323,563
Loading xslF345X03/doc4.xml…